Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACE Inhibition and Cardiac Allograft Vasculopathy

NCT01078363 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01078363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01078363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACE Inhibition and Cardiac Allograft Vasculopathy
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2009
Completion date
April 30, 2015
Enrollment
96 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac allograft vasculopathy